MT-6402

· Molecular Templates, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MT-6402, covering 2024-11-04 to 2024-11-04. Get the full timeline:

Most recent: Clinical Trial Update: Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1 [Phase 1]